Comments: US HB3839 | 2023-2024 | 118th Congress
Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Spectrum: Bipartisan Bill
Status: (Introduced) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]
Text: Latest bill text (Introduced) [PDF]
Spectrum: Bipartisan Bill
Status: (Introduced) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]
Text: Latest bill text (Introduced) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB3839 at this time. | |||||
